Information  X 
Enter a valid email address

Impellam Group plc (IPEL)

  Print          Annual reports

Tuesday 06 April, 2021

Impellam Group plc

Transaction in Own Shares

RNS Number : 5632U
Impellam Group plc
06 April 2021
 

6 April 2021

Impellam Group plc

("Impellam" or the "Company")

Transaction in Own Shares

Impellam Group PLC, the 2nd largest staffing business in the UK and 6th largest MSP worldwide, announces that it has made the following purchases of ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") to be cancelled pursuant to the Share Purchase Plan announced on 25 January 2021.

Date of purchase

29 March 2021

Number of Ordinary Shares purchased (aggregated volume):

3,353

Highest Price paid per Ordinary Share (£):

2.70

Lowest Price paid per Ordinary Share (£):

2.70

Volume Weighted Average Price paid per Ordinary Share (£):

2.70

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

Following cancellation of the Ordinary Shares purchased, the number of Ordinary Shares in issue and admitted to trading on AIM will be reduced to 45,840,955. This figure of 45,840,955 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Share Purchase Plan.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Canaccord Genuity Limited on behalf of Impellam.

Individual transactions:

Number of shares purchased

Trading venue

3,353

270.00

13:31:06

London Stock Exchange

 

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Bobbie Hilliam

Georgina McCooke

 

020 7523 8150

 

Note to Editors:

Impellam is the second largest   1    staffing company in the UK and sixth largest   2    Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

For more information about Impellam Group please visit:    www.impellam.com    

1  By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts.  Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSSSFIMEFSEDL

a d v e r t i s e m e n t